Literature DB >> 18635548

CD95 stimulation results in the formation of a novel death effector domain protein-containing complex.

Inna N Lavrik1, Thomas Mock, Alexander Golks, Julia C Hoffmann, Simone Baumann, Peter H Krammer.   

Abstract

Stimulation of CD95 (APO-1/Fas) by its natural ligand CD95L (APO-1L/FasL) leads to the formation of the death-inducing signaling complex. Here we report that upon CD95 stimulation in several T and B cell lines, a novel signaling complex is formed, which we term complex II. Complex II is composed of the death effector domain proteins as follows: procaspase-8a/b, three isoforms of c-FLIP (c-FLIP(L), c-FLIP(S), c-FLIP(R)), and FADD. Notably, complex II does not contain CD95. Based on our findings we suggest that CD95 signaling includes two steps. The first step involves formation of the death-inducing signaling complex at the cell membrane. The second step involves formation of the cytosolic death effector domain protein-containing complex that may play an important role in amplification of caspase activation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18635548      PMCID: PMC3258909          DOI: 10.1074/jbc.M800823200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  38 in total

1.  Differences between CD95 type I and II cells detected with the CD95 ligand.

Authors:  I Schmitz; H Walczak; P H Krammer; M E Peter
Journal:  Cell Death Differ       Date:  1999-09       Impact factor: 15.828

2.  Cellular FLICE-inhibitory protein splice variants inhibit different steps of caspase-8 activation at the CD95 death-inducing signaling complex.

Authors:  A Krueger; I Schmitz; S Baumann; P H Krammer; S Kirchhoff
Journal:  J Biol Chem       Date:  2001-03-05       Impact factor: 5.157

3.  The active caspase-8 heterotetramer is formed at the CD95 DISC.

Authors:  I Lavrik; A Krueger; I Schmitz; S Baumann; H Weyd; P H Krammer; S Kirchhoff
Journal:  Cell Death Differ       Date:  2003-01       Impact factor: 15.828

4.  Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes.

Authors:  Olivier Micheau; Jürg Tschopp
Journal:  Cell       Date:  2003-07-25       Impact factor: 41.582

5.  Distinct signaling pathways in TRAIL- versus tumor necrosis factor-induced apoptosis.

Authors:  Zhaoyu Jin; Wafik S El-Deiry
Journal:  Mol Cell Biol       Date:  2006-08-28       Impact factor: 4.272

6.  Molecular ordering of the initial signaling events of CD95.

Authors:  Alicia Algeciras-Schimnich; Le Shen; Bryan C Barnhart; Andrea E Murmann; Janis K Burkhardt; Marcus E Peter
Journal:  Mol Cell Biol       Date:  2002-01       Impact factor: 4.272

Review 7.  CD95's deadly mission in the immune system.

Authors:  P H Krammer
Journal:  Nature       Date:  2000-10-12       Impact factor: 49.962

Review 8.  The CD95(APO-1/Fas) DISC and beyond.

Authors:  M E Peter; P H Krammer
Journal:  Cell Death Differ       Date:  2003-01       Impact factor: 15.828

9.  Caspase-10 is recruited to and activated at the native TRAIL and CD95 death-inducing signalling complexes in a FADD-dependent manner but can not functionally substitute caspase-8.

Authors:  Martin R Sprick; Eva Rieser; Heiko Stahl; Anne Grosse-Wilde; Markus A Weigand; Henning Walczak
Journal:  EMBO J       Date:  2002-09-02       Impact factor: 11.598

10.  NFkappaB activation by Fas is mediated through FADD, caspase-8, and RIP and is inhibited by FLIP.

Authors:  Sebastian Kreuz; Daniela Siegmund; Jost-Julian Rumpf; Dierk Samel; Martin Leverkus; Ottmar Janssen; Georg Häcker; Oliver Dittrich-Breiholz; Michael Kracht; Peter Scheurich; Harald Wajant
Journal:  J Cell Biol       Date:  2004-08-02       Impact factor: 10.539

View more
  16 in total

Review 1.  Regulation of CD95/Fas signaling at the DISC.

Authors:  I N Lavrik; P H Krammer
Journal:  Cell Death Differ       Date:  2011-11-11       Impact factor: 15.828

Review 2.  Death receptor signal transducers: nodes of coordination in immune signaling networks.

Authors:  Nicholas S Wilson; Vishva Dixit; Avi Ashkenazi
Journal:  Nat Immunol       Date:  2009-03-19       Impact factor: 25.606

Review 3.  Life and death by death receptors.

Authors:  Maria Eugenia Guicciardi; Gregory J Gores
Journal:  FASEB J       Date:  2009-01-13       Impact factor: 5.191

Review 4.  Cell death controlling complexes and their potential therapeutic role.

Authors:  Alexey V Zamaraev; Gelina S Kopeina; Boris Zhivotovsky; Inna N Lavrik
Journal:  Cell Mol Life Sci       Date:  2014-10-17       Impact factor: 9.261

5.  GDP-mannose-4,6-dehydratase (GMDS) deficiency renders colon cancer cells resistant to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) receptor- and CD95-mediated apoptosis by inhibiting complex II formation.

Authors:  Kenta Moriwaki; Shinichiro Shinzaki; Eiji Miyoshi
Journal:  J Biol Chem       Date:  2011-10-25       Impact factor: 5.157

6.  Deregulation of apoptotic factors Bcl-xL and Bax confers apoptotic resistance to myeloid-derived suppressor cells and contributes to their persistence in cancer.

Authors:  Xiaolin Hu; Kankana Bardhan; Amy V Paschall; Dafeng Yang; Jennifer L Waller; Mary Anne Park; Asha Nayak-Kapoor; Thomas A Samuel; Scott I Abrams; Kebin Liu
Journal:  J Biol Chem       Date:  2013-05-15       Impact factor: 5.157

7.  IFN regulatory factor 8 sensitizes soft tissue sarcoma cells to death receptor-initiated apoptosis via repression of FLICE-like protein expression.

Authors:  Dafeng Yang; Suizhao Wang; Craig Brooks; Zheng Dong; Patricia V Schoenlein; Vijay Kumar; Xinshou Ouyang; Huabao Xiong; Guy Lahat; Andrea Hayes-Jordan; Alexander Lazar; Raphael Pollock; Dina Lev; Kebin Liu
Journal:  Cancer Res       Date:  2009-01-20       Impact factor: 12.701

8.  Apoptotic potential of Fas-associated death domain on regulation of cell death regulatory protein cFLIP and death receptor mediated apoptosis in HEK 293T cells.

Authors:  Kishu Ranjan; Avadhesha Surolia; Chandramani Pathak
Journal:  J Cell Commun Signal       Date:  2012-07-12       Impact factor: 5.782

Review 9.  Cell death, dysglycemia and myocardial infarction.

Authors:  Xiao-Fang Tian; Ming-Xia Cui; Shi-Wei Yang; Yu-Jie Zhou; DA-Yi Hu
Journal:  Biomed Rep       Date:  2013-02-25

10.  Cellular IAPs inhibit a cryptic CD95-induced cell death by limiting RIP1 kinase recruitment.

Authors:  Peter Geserick; Mike Hupe; Maryline Moulin; W Wei-Lynn Wong; Maria Feoktistova; Beate Kellert; Harald Gollnick; John Silke; Martin Leverkus
Journal:  J Cell Biol       Date:  2009-12-28       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.